ATAI Life Sciences NV
NASDAQ:ATAI

Watchlist Manager
ATAI Life Sciences NV Logo
ATAI Life Sciences NV
NASDAQ:ATAI
Watchlist
Price: 2.32 USD 0.43% Market Closed
Market Cap: 463.5m USD

Wall Street
Price Targets

ATAI Price Targets Summary
ATAI Life Sciences NV

Wall Street analysts forecast ATAI stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for ATAI is 8.84 USD with a low forecast of 5.05 USD and a high forecast of 11.55 USD.

Lowest
Price Target
5.05 USD
118% Upside
Average
Price Target
8.84 USD
281% Upside
Highest
Price Target
11.55 USD
398% Upside
ATAI Life Sciences NV Competitors:
Price Targets
VY4
SNDL Inc
175% Upside
GLAND
Gland Pharma Ltd
4% Upside
ACB
Aurora Cannabis Inc
45% Upside
000756
Shandong Xinhua Pharmaceutical Co Ltd
30% Downside
APLLTD
Alembic Pharmaceuticals Ltd
7% Upside
000100
Yuhan Corp
38% Upside
XERS
Xeris Biopharma Holdings Inc
26% Upside
4015
Jamjoom Pharmaceuticals Factory Company SJSC
16% Upside

Revenue
Forecast

Revenue Estimate
ATAI Life Sciences NV

The compound annual growth rate of ATAI Life Sciences NV's revenue for the next 3 years is 539%.

N/A
Past Growth
539%
Estimated Growth
Estimates Accuracy
-12%
Average Miss

Operating Income
Forecast

Operating Income Estimate
ATAI Life Sciences NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-3%
Average Miss

Net Income
Forecast

Net Income Estimate
ATAI Life Sciences NV

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-15%
Average Miss
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is ATAI's stock price target?
Price Target
8.84 USD

According to Wall Street analysts, the average 1-year price target for ATAI is 8.84 USD with a low forecast of 5.05 USD and a high forecast of 11.55 USD.

What is ATAI Life Sciences NV's Revenue forecast?
Projected CAGR
539%

The compound annual growth rate of ATAI Life Sciences NV's revenue for the next 3 years is 539%.

Back to Top